(erythromycin 3%-benzoyl peroxide 5% topical gel)
For Dermatological Use Only – Not for Ophthalmic Use
Benzamycin® Pak contains erythromycin [(3R*,4S*,5S*,6R*,7R*,9R*,11R*,12R*,13S*,14R*)-4-[(2,6-dideoxy-3-C-
xylo-hexopyranosyl]oxy]oxacyclotetradecane-2,10-dione]. Erythromycin is a macrolide antibiotic produced from a strain of Saccharopolyspora erythraea (formerly Streptomyces erythreus). It is a base and readily forms salts with acids.
Benzamycin ® Pak is indicated for the topical treatment of acne vulgaris.
Media Articles Related to Benzamycin (Erythromycin / Benzoyl Peroxide Topical)
Better Contraceptive Knowledge Can Aid in Safe Use of Acne Drug: Study
Source: MedicineNet Acne Specialty [2015.02.05]
Title: Better Contraceptive Knowledge Can Aid in Safe Use of Acne Drug: Study
Category: Health News
Created: 2/4/2015 12:00:00 AM
Last Editorial Review: 2/5/2015 12:00:00 AM
Source: MedicineNet Boils Specialty [2014.10.17]
Title: Acne (Pimples)
Category: Diseases and Conditions
Created: 12/31/1997 12:00:00 AM
Last Editorial Review: 10/17/2014 12:00:00 AM
Acne Medication May Raise Risk of Eye Infections
Source: MedicineNet Chalazion Specialty [2012.06.01]
Title: Acne Medication May Raise Risk of Eye Infections
Category: Health News
Created: 5/31/2012 2:05:00 PM
Last Editorial Review: 6/1/2012 12:00:00 AM
Clinical Trials Related to Benzamycin (Erythromycin / Benzoyl Peroxide Topical)
Patients Response to Early Switch To Oral:Osteomyelitis Study [Not yet recruiting]
Based on the current literature, investigators hypothesize that patients with osteomyelitis
who are treated with the standard approach of intravenous antibiotics for the full duration
of therapy will have the same clinical outcomes as patients treated with the experimental
approach of intravenous antibiotics with early switch to oral antibiotics.
The primary objective of this study is to compare patients with osteomyelitis treated with
the standard approach of intravenous antibiotics for the full duration of therapy versus
patients treated with intravenous antibiotics with an early switch to oral antibiotics in
relation to clinical outcomes at 12 months after discontinuation of antibiotic therapy.
Secondary objectives of the study include the evaluation of adverse events related to the
use of antibiotics as well as the cost of care evaluated from the hospital perspective.